The US FDA is alerting healthcare providers about import alerts for certain medical devices manufactured in Japan by Olympus Medical Systems Corporation (Olympus) and its subsidiaries.
Despite extensive and ongoing efforts to address compliance issues, FDA continues to have concerns related to outstanding Quality System regulation violations by Olympus, the agency said in a press release. Therefore, the FDA has issued import alerts to prevent future shipments of certain devices from entering the United States, including specific models of:
- Ureterorenoscopes, which are used to perform various diagnostic and therapeutic procedures within the urinary tract
- Bronchoscopes, which are used to perform various diagnostic and therapeutic procedures in the respiratory tract
- Laparoscopes, which are used to perform various diagnostic and therapeutic procedures in the abdomen and pelvis
- Automated endoscope reprocessors, which are used to reprocess various endoscopes
FDA Recommendations
The FDA recommends that healthcare providers:
- Be aware of the FDA import alerts for certain medical devices manufactured in Japan by Olympus Medical Systems Corporation (Olympus) and its subsidiaries, under which the devices will be refused entry into the US:
- Import Alert 89-04 for failure to meet quality system regulation requirements at Aizu, an Olympus manufacturing site in Japan
- Refer to the table below for model numbers and Unique Device Identifiers (UDI) for the devices included in the import alerts.
- Be aware that the import alert does not apply to related products (such as replacement parts, connectors, or single use consumables) used with the devices subject to import alert.
- If you are currently using devices subject to the import alert, you may continue using these devices if you are not experiencing any problems with the devices.
- Follow the labeling and reprocessing instructions to properly clean and reprocess the devices, including accessory components.
- Do not use damaged devices or those that have failed a leak test, as they could be a potential source of contamination.
- Develop schedules for routine inspection and periodic maintenance in accordance with manufacturer’s instructions.
- Discuss the benefits and risks associated with procedures involving these devices with your patients. The FDA does not recommend that procedures be canceled or delayed without discussion of the benefits and risks between the health care provider and patient.
- Complete prompt reporting of adverse events to help us identify and better understand the risks associated with these devices.
